Agglutinins to anaerobic bacteria in Crohn's disease and in Indian patients with diarrhoea.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 6708086)

Published in J Med Microbiol on April 01, 1984

Authors

B Howells, N Matthews, J F Mayberry, J Rhodes

Articles by these authors

The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut (2001) 10.07

Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) (1982) 4.08

An oral preparation to release drugs in the human colon. Br J Clin Pharmacol (1982) 3.49

Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. Br J Cancer (1978) 3.38

Incidence of Crohn's disease in Cardiff between 1934-1977. Gut (1979) 3.35

Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90

Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86

Myelopoiesis in the zebrafish, Danio rerio. Blood (2001) 2.67

Natural history of patients with x-ray-negative dyspepsia in general practice. Br Med J (1972) 2.67

Breakfast and dietary aspects of Crohn's disease. Br Med J (1978) 2.57

Tumour-necrosis factor from the rabbit. II. Production by monocytes. Br J Cancer (1978) 2.48

How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc (2000) 2.42

Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1982) 2.32

Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28

Disodium cromoglycate in the treatment of chronic proctitis. Gut (1975) 2.21

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut (2002) 2.13

Macrophage heterogeneity in receptor activity: the activation of macrophage Fc receptor function in vivo and in vitro. J Immunol (1975) 2.07

Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut (1988) 2.05

Epidemiological aspects of Crohn's disease: a review of the literature. Gut (1984) 2.04

Patients' views on how to run hospital outpatient clinics. J R Soc Med (1991) 2.03

Smoking habits in psoriasis: a case control study. Br J Dermatol (1992) 2.03

Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut (1992) 1.96

Osteoporosis in patients with inflammatory bowel disease. Gut (1987) 1.95

Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg (1988) 1.91

Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J (1980) 1.88

European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut (1986) 1.86

Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis. Br J Clin Pharmacol (1983) 1.80

Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut (1993) 1.79

Production of an anti-tumour cytotoxin by human monocytes. Immunology (1981) 1.78

The Crohn's and Colitis Knowledge Score: a test for measuring patient knowledge in inflammatory bowel disease. Am J Gastroenterol (1999) 1.74

Meta-analysis: mortality in Crohn's disease. Aliment Pharmacol Ther (2007) 1.73

Altered bowel habit and menstruation. Lancet (1976) 1.73

Transoesophageal echocardiography during scoliosis repair: comparison with CVP monitoring. Can J Anaesth (1998) 1.71

Q fever in an urban area. Lancet (1982) 1.70

Liver biopsy under ultrasound control: implications for training in the Calman era. Gut (1999) 1.70

Information requirements and sedation preferences of patients undergoing endoscopy of the upper gastrointestinal tract. Endoscopy (1991) 1.69

Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect Immun (2000) 1.69

Monitoring of sympathetic tone to assess postoperative pain: skin conductance vs surgical stress index. Anaesthesia (2009) 1.67

Studies of incidence and prevalence of achalasia in the Nottingham area. Q J Med (1985) 1.64

Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut (1986) 1.63

Mortality in Crohn's disease. Q J Med (1980) 1.62

Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion (1987) 1.60

Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest (1990) 1.59

Treating irritable bowel syndrome with peppermint oil. Br Med J (1979) 1.57

pH of the contents of the duodenal bulb in relation to duodenal ulcer. Gut (1966) 1.57

[Not Available]. BioDrugs (1997) 1.56

Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire. Q J Med (1992) 1.56

Controlled trial of azathioprine in Crohn's disease. Lancet (1971) 1.56

Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment Pharmacol Ther (2000) 1.55

Life insurance and inflammatory bowel disease: is there discrimination against patients? Int J Colorectal Dis (1996) 1.54

Complications of carbenoxolone therapy. Br Med J (1974) 1.54

Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system. Br J Cancer (1976) 1.53

The compulsory removal of elderly people in England and Wales under Section 47 of the National Assistance Act and its 1951 Amendment: a survey of its implementation in England and Wales in 1988 and 1989. Age Ageing (1995) 1.52

The effect of healing on bile reflux in gastric ulcer. Gut (1971) 1.51

What the patient wants to know about Crohn's disease. J Clin Gastroenterol (1983) 1.48

Tumour-necrosis factor from the rabbit. IV. Purification and chemical characterization. Br J Cancer (1980) 1.47

Altered expression of human monocyte Fc receptors in malignant disease. Nature (1977) 1.46

Treatment of ulcerative colitis with oral 5-aminosalicyclic acid in patients unable to take sulphasalazine. Lancet (1983) 1.44

Smoking and prevention. Respir Med (1991) 1.42

Increased sugar consumption in Crohn's disease. Digestion (1980) 1.42

An audit of Crohn's disease in a defined population. J R Coll Physicians Lond (1983) 1.42

Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential. J Mol Med (Berl) (1996) 1.41

Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol (1996) 1.41

The relation of hand skin-fold thickness to bone mineral density in patients with Crohn's disease. Eur J Gastroenterol Hepatol (1997) 1.41

Information assessment by patients of a booklet on Crohn's disease. Public Health (1985) 1.41

Allescheria boydii infections in the immunosuppressed host. Am J Med (1977) 1.40

Petit mal status: an unusual cause of confusion. Br J Hosp Med (1990) 1.40

Triiodothyronine in the recovery of stunned myocardium in dogs. Ann Thorac Surg (1991) 1.40

Diagnosis of oesophageal spasm by ergometrine provocation. Gut (1982) 1.40

Acidity at different sites in the proximal duodenum of normal subjects and patients with duodenal ulcer. Gut (1966) 1.40

Issues of consent in colonoscopy: if a patient says 'stop' should we continue? J R Soc Med (1999) 1.39

Elderly people at home who cannot cope. Lancet (1991) 1.39

Genomic deletion marking an emerging subclone of Francisella tularensis subsp. holarctica in France and the Iberian Peninsula. Appl Environ Microbiol (2007) 1.39

A study of swallowing difficulties in first degree relatives of patients with achalasia. Thorax (1985) 1.38

A nationwide survey of liver biopsy--is there a need to increase resources, manpower and training? Hepatogastroenterology (1994) 1.38

Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet (1983) 1.37

Etiology of gastric ulcer. Gastroenterology (1972) 1.37

Bile damage to the gastric mucosal barrier: the influence of pH and bile acid concentration. Gastroenterology (1971) 1.36

Achalasia in the city of Cardiff from 1926 to 1977. Digestion (1980) 1.36

Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther (2007) 1.35

The practice of rectal examination. Postgrad Med J (1991) 1.34

'Esophageal angina' as the cause of chest pain. JAMA (1982) 1.33

The gastroenterology service: a survey of general practitioners' requirements. J R Soc Med (1993) 1.33

Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet (1999) 1.31

The role of acupuncture in the treatment of irritable bowel syndrome: a pilot study. Hepatogastroenterology (1997) 1.31

Incidence of ulcerative colitis in the Cardiff region 1968-1977. Gut (1984) 1.29

Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J Interv Card Electrophysiol (2000) 1.29

Has the rising incidence of Crohn's disease reached a plateau? Br Med J (Clin Res Ed) (1982) 1.29

Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut (1985) 1.29